Peer Review History
Original SubmissionNovember 11, 2020 |
---|
Transfer Alert
This paper was transferred from another journal. As a result, its full editorial history (including decision letters, peer reviews and author responses) may not be present.
PONE-D-20-35487 The Implementation, Use and Sustainability of a Clinical Decision Support System for Medication Optimisation in Primary Care: A Qualitative Evaluation Using Normalisation Process Theory PLOS ONE Dear Dr. Jeffries, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Reviewers agreed that this work is interesting, nevertheless, more explanations are needed regarding methodology and the replicability of the results e.g., items of the interviews, coding etc. Moreover, a more detail analysis is asked by both the reviewers regarding the four themes/constructs. I suggest authors should try to comply with all the indications of both the reviewers as these are quite reasonable and well aligned. Please submit your revised manuscript by Jan 29 2021 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols We look forward to receiving your revised manuscript. Kind regards, Simone Borsci, Ph.D. Academic Editor PLOS ONE Journal Requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 2. When reporting the results of qualitative research, we suggest consulting the COREQ guidelines: http://intqhc.oxfordjournals.org/content/19/6/349. In this case, please consider including more information on the number of interviewers, their training and characteristics.Moreover, please provide the interview guide used as a Supplementary file. 3. In your Data Availability statement, you have not specified where the minimal data set underlying the results described in your manuscript can be found. PLOS defines a study's minimal data set as the underlying data used to reach the conclusions drawn in the manuscript and any additional data required to replicate the reported study findings in their entirety. All PLOS journals require that the minimal data set be made fully available. For more information about our data policy, please see http://journals.plos.org/plosone/s/data-availability. Upon re-submitting your revised manuscript, please upload your study’s minimal underlying data set as either Supporting Information files or to a stable, public repository and include the relevant URLs, DOIs, or accession numbers within your revised cover letter. For a list of acceptable repositories, please see http://journals.plos.org/plosone/s/data-availability#loc-recommended-repositories. Any potentially identifying patient information must be fully anonymized. Important: If there are ethical or legal restrictions to sharing your data publicly, please explain these restrictions in detail. Please see our guidelines for more information on what we consider unacceptable restrictions to publicly sharing data: http://journals.plos.org/plosone/s/data-availability#loc-unacceptable-data-access-restrictions. Note that it is not acceptable for the authors to be the sole named individuals responsible for ensuring data access. We will update your Data Availability statement to reflect the information you provide in your cover letter. 4. Please include a copy of Table 2 which you refer to in your text on page 8. 5. Please include captions for your Supporting Information files at the end of your manuscript, and update any in-text citations to match accordingly. Please see our Supporting Information guidelines for more information: http://journals.plos.org/plosone/s/supporting-information. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes Reviewer #2: Yes ********** 2. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: N/A Reviewer #2: N/A ********** 3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: No ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: Yes ********** 5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: Thanks for providing the opportunity to review manuscript entitled “The Implementation, Use and Sustainability of a Clinical Decision Support System for Medication Optimisation in Primary Care: A Qualitative Evaluation Using Normalisation Process Theory”. This qualitative study evaluates the application of a clinical decision support system in general practices in the English National Health Service (NHS). I have a number of comments on the manuscript as follows. Major comments: 1. Use of the Normalisation Process Theory: The authors have repeatedly highlighted the use of the NPT including in the title, abstract and all sections of the manuscript. However, they have neither given details of the NPT nor a strong justification of it as a theoretical framework for use in the current study. Table 1 provides includes various constructs of the NPT but there is limited explanation/description of the constructs. No source is given for Table 1. 2. Data are collected from different types of participants representing diverse organisations. A flow diagram showing the types and number of organisations and participants would be useful. 3. Data were collected by semi-structured interviews but and the interview guide/schedule was guided by the NPT but there is no information about the content of the interview guide/schedule its piloting if any. 4. The authors created codes and themes from qualitative interviews data. Inclusion of a map / dendrogram of codes and themes would help readers and audience especially senior policy makers, managers and clinicians who have very little time to read elaborate qualitative quotes reported in the manuscripts 5. Results section reports a number of themes and lengthy quotes, which have been reported under four major constructs of the NPT. Presentation of these themes in a grid comprising the NPT constructs could be helpful. NPT constructs reported in Table include sub-constructs, which might be useful to report the themes developed under the relevant sub-constructs. 6. Results show that cost saving was the main aim of the CCGs while patient safety was the main objective of GPs to use the CDS system. These are two divergent objectives, which need to be discussed, especially how different views were / could be reconciled and whether there would be any implications for addressing these issues. 7. Neither the introduction section nor the discussion section provided a review of current literature on the use, advantages and limitations of the NPT in the context of CDS system. Minor comments 8. In the abstract, methods section does not report the number of different participating organisations, which need to be reported for each type of organisation involved. This section should report the mean/median duration of a typical interview. It is not clear what does the term ‘Staff stakeholders’ refers to. The author report that they created “themes developed into frameworks’. Should the framework be constructs? 9. BACKGROUND: Please spell out the ‘NHS’ (line 78, page 4). 10. METHODS: The authors report “Practices and CCG areas” (lines 128, page 6). Should this be ‘General practices and CCG area’? 11. METHODS: The authors report that “Semi-structured interviews were conducted with a range of stakeholders” (lines 154-55, page 6). Please specify who and how many were they. 12. Could you please add the date of ethics approval? 13. Results: There were four group interviews (lines 199, page 8). Could you please report the number of interviewees in each of these group interviews and who the participants were? 14. RESULTS: The authors mapped the main findings into 4 constructs of the NPT (liens 202-, page 8), which suggests that all themes fitted in the four constructs. Wondering whether there were there any issues that did not fit in the give NPR constructs. If so, please report them. 15. Some quotes are very long e.g. quote from CCG pharmacist 4 – lines 406-419 and GP” – lines 527-538. Long quotes could be reduced by truncating them. 16. RESULTS: The authors report “Learning was helped by depersonalised feedback.” (Lines 596, page 21). Who and how depersonalised feedback was given? 17. DICUSSION: It is hard to find the novelty and contributions of the study to the body of knowledge. 18. STRENGTHS & LIMITATIONS: The strengths are mostly around the use of NPT whereas the strengths should be about the findings of the study. Reviewer #2: This paper presents a qualitative inquiry into factors surrounding the use of a clinical decision support system for medication. The authors described a broad effort to interview a range of participants with differing perspectives, all taken from the development, implementation, and use of a clinical decision support system in English care contexts. Interviews conducted from the perspective of Normalisation Process Theory are presented, with numerous quotes used to paint a rich picture of respondents' attitudes toward these systems. The paper is well-written, the methods are clear, and the results seem plausible. That said, I have some concerns with the methodology and the presentation. of the results. Regarding methodology, some additional context on normalization process theory is needed. The phrase "middle-range theory" may be familiar to sociologists, but clinical and biomedical informatics readers might benefit from an introduction. Specifically, how does NPT add to theories such as UTAUT, which assesses intention to use through both individual and organizational perspectives, or distributed cognition theories discussing how systems are used in organizational contexts? None of this is to say that NPT is inappropriate, but the paper would benefit from some deeper discussion of the methods. The description of the results made for an interesting read - the quotes were informative and thought-provoking. However, the results section read more like a preliminary draft than a finished paper - far too many quotes and far too little structure. Although I can certainly understand the desire to include too much discussion in the results section, I would have found it helpful to have more summary and analysis. Perhaps some tables summarizing key themes under each of the four constructs? Also, there was very little clarity of how these concepts and observations differed across the different groups of respondents. These difficulties persist into the discussion. Although the authors appropriately provide a nice description of how their results are consistent with observations from prior studies, there is less clarity as to the novel insights provided by this paper. It would be helpful if the authors were able to summarize their contributions more concisely. Regarding the limitations of this study, I am concerned that the authors do not include any discussion of the utilization of the systems involved. Extensive prior literature, and some of the comments in this paper, clearly show that clinicians often disregard drug related alerts. This suggests that there may be a disconnect - it's entirely possible that some of the positive statements about the CDS systems might have, in fact, been made by clinicians who regularly dismissed or ignored system recommendations. Ideally, this qualitative detail might be accompanied by some assessments of the rates of utilization of the system, but I understand that this data might be hard to get. However, the authors should consider a careful look into the possibility that the interview results are biased, particularly since they were conducted outside of care contexts and may be impacted by demand characteristics (ie, the tendency of respondents to answer in a manner that might make them "look good" to the interviewers). Some discussion of these questions would be appropriate. Finally, regarding data sharing, more detail is needed. Even if transcripts of interviews cannot be shared, the authors should be able to share their codebook, any summary statistics, and other related material. - data sharing ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step. |
Revision 1 |
PONE-D-20-35487R1 The Implementation, Use and Sustainability of a Clinical Decision Support System for Medication Optimisation in Primary Care: A Qualitative Evaluation Using Normalisation Process Theory PLOS ONE Dear Dr. Jeffries, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. One of the reviewers still has some comments which I believe are helpful to further improve the manuscript. Please revise in tune, and resubmit. Then I will personally check the revision without involving the reviewer and if satisfactory I will accept the article. Please submit your revised manuscript by May 26 2021 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. We look forward to receiving your revised manuscript. Kind regards, Simone Borsci, Ph.D. Academic Editor PLOS ONE Journal Requirements: Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation. Reviewer #1: (No Response) Reviewer #2: All comments have been addressed ********** 2. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes Reviewer #2: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: N/A Reviewer #2: N/A ********** 4. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: No Reviewer #2: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: Yes ********** 6. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: Thanks to the authors for revising and resubmitting the manuscript entitled “The Implementation, Use and Sustainability of a Clinical Decision Support System for Medication Optimisation in Primary Care: A Qualitative Evaluation Using Normalisation Process Theory”, which is improved. However, it needs further revision as suggested below. TITLE: The title of the manuscript is too long and it needs to be shortened such as removing ‘Using Normalisation Process Theory’. ABSTRACT: The abstracts need improvement especially the findings section by reporting the key findings as per the major themes and / or constructs of the Normalisation Process Theory, as reported in Table 3 and the main text. For example: COHERENCE (purpose of the system like Enhancing medication safety and improving cost effectiveness; Relationship of users to the technology; Engagement and communication between different stakeholders), COGNITIVE PARTICIPATION (Management of the profile of alerts) , COLLECTIVE ACTION (Prescribing in general practice; patient and population characteristics and engagement with patients; knowledge) REFLEXIVE MONITORING (Sustaining the use of the CDS through maintenance and customisation; Learning and behaviour change). The authors also mention that “there was a range of contextual factors’, which have not been reported. Could the authors the key contextual factors identified. In addition, background and methods sections in the abstract may be shortened. Conclusion: The conclusion only focuses on the safety and alerts but it does not reflect anything about cost saving which was the primary aim of the CCGs. This aspect needs to be reflected in the conclusion in the abstract, as reported in the conclusion section in the main text. BACKGROUND: CDC (page 4, lines 84-85): Could the authors add a citation/reference about the CSD system evaluated. In addition, the authors call the CDS sometimes as a system (page 4, line 87 and so on) and sometimes as software (page 4, lines 84-85). Is it a system or software? Please be precise and consistent. CCG (page 4, line 87), Please spell out the acronym CCG here as it is mentioned for the first time, which has been spelled out later on page 5 (line 123). METHODS: National Health Service (Pages 5-, lines 125-126): Acronym for the term ‘National Health Service’ has been given already in page 4, line 78; hence use only the acronym here (lines 125-126, page 5-6) Follow-up interviews (page 7, lines 1163-64): Follow-up interviews were conducted about 12 months after the first interviews. This is a long period. Did the follow-up interviews were conducted with the same persons / interviewees working on the same positions as in the first interviews? Were there any new people, and how many, involved in the follow-up interviews. Shopping vouchers (page 7, lines 172-173): The authors paid £20 shopping vouchers to participants. Was the payment included in the ethics application? Did the authors paid/ gave vouchers to all participants or some participants and who were they. It seems unbelievable that a GP will accept/ask for £20 voucher for an interview! Most of the participants were employees of either the NHS or CCGs hence paid by them so why they were reimbursed for their time in the study? Acronym of Normalisation Process Theory: The authors have reported Normalisation Process Theory (NPT) on page 4, lines 107-08 and again they report Normalisation Process Theory (NPT) on page 7, line 179). Please report only NPT on page 7, line 179. DISCUSSION: Strengths and limitations (page 27, lines 776-777): The authors have stated that This was the first qualitative study to utilise NPT to understand the complex processes that influenced the implementation and sustained use in primary care of a CDS system“. However, in the Methods section - Theoretical Framework: Normalization process theory (page 8, lines 192-205), they have reported that the NPT has been used in the evaluations of several health care interventional studies so why this study is the first to use the NPT in this study. The authors may check this claim. Reviewer #2: (No Response) ********** 7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: Yes: Syed Ghulam Sarwar Shah Reviewer #2: Yes: Harry Hochheiser [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step. |
Revision 2 |
The Implementation, Use and Sustainability of a Clinical Decision Support System for Medication Optimisation in Primary Care: A Qualitative Evaluation PONE-D-20-35487R2 Dear Dr. Jeffries, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Simone Borsci, Ph.D. Academic Editor PLOS ONE |
Formally Accepted |
PONE-D-20-35487R2 The Implementation, Use and Sustainability of a Clinical Decision Support System for Medication Optimisation in Primary Care: A Qualitative Evaluation Dear Dr. Jeffries: I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department. If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org. If we can help with anything else, please email us at plosone@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Simone Borsci Academic Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .